Cargando…
Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy
As the First-In-Human study of in situ gene therapy using an adenovirus vector carrying the human REIC (reduced expression in immortalized cell)/Dkk-3 gene (Ad-REIC), we conducted neoadjuvant intraprostatic injections in patients with high-risk localized prostate cancer undergoing radical prostatect...
Autores principales: | Kumon, H, Ariyoshi, Y, Sasaki, K, Sadahira, T, Araki, M, Ebara, S, Yanai, H, Watanabe, M, Nasu, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116477/ https://www.ncbi.nlm.nih.gov/pubmed/27767086 http://dx.doi.org/10.1038/cgt.2016.53 |
Ejemplares similares
-
Feasibility of Neoadjuvant Ad‐REIC Gene Therapy in Patients with High‐Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
por: Kumon, Hiromi, et al.
Publicado: (2015) -
Adenovirus-mediated REIC/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review)
por: WATANABE, MASAMI, et al.
Publicado: (2014) -
Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy
por: Kumon, Hiromi, et al.
Publicado: (2015) -
Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity
por: Ochiai, Kazuhiko, et al.
Publicado: (2015) -
A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector
por: WATANABE, MASAMI, et al.
Publicado: (2014)